Make a donation Start a fundraiser
  • Our Story
    • Our Story
    • Fiona Elsey’s Dream
    • Governance
      • Board of Directors
      • Donor Reports
      • Terms & Policies
    • Community Partners
    • Supporter Stories
    • News & Media
  • Research
    • Our Research
    • Research Projects
      • Ovarian Cancer
      • Immunology
      • Chronic Lymphocytic Leukemia (CLL)
      • Langerhans Cell Histocytosis
      • Bowel cancer
      • Breast cancer
      • Renal cancer
    • Research Team
    • Collaborations
    • Publications
  • Get Involved
    • Get Involved
    • Donate
    • Fundraise for Research
    • Bendigo Telco
    • Leave a Gift in Your Will
    • Workplace Giving
    • Volunteer
    • Grain For Hope appeal
  • Events
    • Upcoming Events
  • Contact Us
  • Our Story
    • Our Story
    • Fiona Elsey’s Dream
    • Governance
      • Board of Directors
      • Donor Reports
      • Terms & Policies
    • Community Partners
    • Supporter Stories
    • News & Media
  • Research
    • Our Research
    • Research Projects
      • Ovarian Cancer
      • Immunology
      • Chronic Lymphocytic Leukemia (CLL)
      • Langerhans Cell Histocytosis
      • Bowel cancer
      • Breast cancer
      • Renal cancer
    • Research Team
    • Collaborations
    • Publications
  • Get Involved
    • Get Involved
    • Donate
    • Fundraise for Research
    • Bendigo Telco
    • Leave a Gift in Your Will
    • Workplace Giving
    • Volunteer
    • Grain For Hope appeal
  • Events
    • Upcoming Events
  • Contact Us
Dr Ruth Escalona

Dr Ruth Escalona

Effects of TGFβ2 on wild type and Tgfbr3 knockout mouse fetal testis

[…]

Read More… from Effects of TGFβ2 on wild type and Tgfbr3 knockout mouse fetal testis

Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion

[…]

Read More… from Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion

Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion

[…]

Read More… from Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion

Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line

[…]

Read More… from Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line

Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets

[…]

Read More… from Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets

Changes in the expression of prostaglandin E and F synthases at induced and spontaneous labour onset in the sheep

[…]

Read More… from Changes in the expression of prostaglandin E and F synthases at induced and spontaneous labour onset in the sheep

Pituitary cell lines and their endocrine applications

[…]

Read More… from Pituitary cell lines and their endocrine applications

Prostaglandin E and F receptor expression and myometrial sensitivity at labor onset in the sheep

[…]

Read More… from Prostaglandin E and F receptor expression and myometrial sensitivity at labor onset in the sheep

Labour-associated regulation of prostaglandin E and F synthesis and action in the ovine amnion and cervix

[…]

Read More… from Labour-associated regulation of prostaglandin E and F synthesis and action in the ovine amnion and cervix

Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan

[…]

Read More… from Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan

Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells

[…]

Read More… from Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells

Reducing betaglycan expression by RNA interference (RNAi) attenuates inhibin bio-activity in LβT2 gonadotrope cells

[…]

Read More… from Reducing betaglycan expression by RNA interference (RNAi) attenuates inhibin bio-activity in LβT2 gonadotrope cells

Fetal testis dysgenesis and compromised Leydig cell function in TGFBR3 (betaglycan) knockout mice

[…]

Read More… from Fetal testis dysgenesis and compromised Leydig cell function in TGFBR3 (betaglycan) knockout mice

Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling

[…]

Read More… from Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling

Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment

[…]

Read More… from Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment

Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

[…]

Read More… from Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

Targeted disruption of JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden.

[…]

Read More… from Targeted disruption of JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden.

Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients.

[…]

Read More… from Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients.

Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells

[…]

Read More… from Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells

The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.

[…]

Read More… from The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.

Paclitaxel-loaded self-assembled lipid nanoparticles as targeted drug delivery systems for the treatment of aggressive ovarian cancer

[…]

Read More… from Paclitaxel-loaded self-assembled lipid nanoparticles as targeted drug delivery systems for the treatment of aggressive ovarian cancer

Tumour Microenvironment and Metabolic Plasticity in Cancer and Cancer Stem Cells: Perspectives on Metabolic and Immune Regulatory Signatures in Chemoresistant Ovarian Cancer Stem Cells.

[…]

Read More… from Tumour Microenvironment and Metabolic Plasticity in Cancer and Cancer Stem Cells: Perspectives on Metabolic and Immune Regulatory Signatures in Chemoresistant Ovarian Cancer Stem Cells.

TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells

[…]

Read More… from TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells

Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment

[…]

Read More… from Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment

In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma.

[…]

Read More… from In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma.

  • Our Story
    • Our Story
    • Fiona Elsey’s Dream
    • Governance
      • Board of Directors
      • Donor Reports
      • Terms & Policies
    • Community Partners
    • Supporter Stories
    • News & Media
  • Research
    • Our Research
    • Research Projects
      • Ovarian Cancer
      • Immunology
      • Chronic Lymphocytic Leukemia (CLL)
      • Langerhans Cell Histocytosis
      • Bowel cancer
      • Breast cancer
      • Renal cancer
    • Research Team
    • Collaborations
    • Publications
  • Get Involved
    • Get Involved
    • Donate
    • Fundraise for Research
    • Bendigo Telco
    • Leave a Gift in Your Will
    • Workplace Giving
    • Volunteer
    • Grain For Hope appeal
  • Events
    • Upcoming Events
  • Contact Us

Fundraisers

News & media

  • Irene’s memory to make a difference to research.
  • Creswick Community Bank
  • Skin cell breakthrough could lead to new treatments.
  • New finding from Breast cancer group.

Contact

admin@fecri.org.au



Phone

03 5331 3101

Location

Ballarat Technology Park
- Central Suite 23,
106-110 Lydiard St Sth
Ballarat Vic 3350

Postal

PO Box 549,
Ballarat VIC 3350

All material © Fiona Elsey Cancer Research Institute.

Site by
Pepper Brandmanagers